Page
%P
-
Article
Open AccessAssessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar
SB3, a biosimilar of Herceptin® (trastuzumab, hereinafter referred to as reference product) is currently approved in the EU, Korea, Australia, the USA, and Brazil for the treatment of human epidermal growth facto...